Prevention of Hypertension and Renal Dysfunction in Dahl Rats by α-Tocopherol
Authors:
Open Access
- 1 July 2003
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 42 (1) , 82-88
Abstract
Although hypertension is a risk factor for the development of end-stage renal disease, not all hypertensive patients progress to develop renal dysfunction. The mechanisms underlying hypertensive nephropathy are poorly understood. The authors have recently shown that the development of hypertension and renal dysfunction is accompanied by an accumulation of partially reduced oxygen and its derivatives, known collectively as reactive oxygen species. In the present study, the effect of a lipid-soluble antioxidant on the development of salt-dependent hypertensive nephropathy was evaluated in the Dahl rat. It was found that a high-salt diet (8% NaCl) led to the development of hypertension, increased renal oxidative stress (superoxide production and 8-epi-prostaglandin F2alpha), and decreased glomerular filtration rate and renal plasma flow in the Dahl salt-sensitive (DSS) rat, and that these adverse effects of salt were prevented by supplementing the high-salt diet with 1000 U/kg chow of alpha-tocopherol. It is well known that urinary cyclic guanosine monophosphate (cGMP) levels are lower in hypertensive DSS rats than in Dahl salt-resistant (DSR) rats on a high-salt diet. Most surprisingly, when supplemented with alpha-tocopherol, DSS rats on an 8% NaCl diet were able to excrete as much cGMP as DSR rats. Taken together, these findings suggest that, in the DSS rat, salt-dependent hypertensive nephropathy and decreased nitric oxide bioavailability are associated with increased oxidative stress, and that antioxidants can preclude these adverse effects of salt feeding, and consequently, prevent salt-dependent hypertension and nephropathy.Keywords
This publication has 36 references indexed in Scilit:
- Roles of NO and oxygen radicals in tubuloglomerular feedback in SHRAmerican Journal of Physiology-Renal Physiology, 2000
- Hypertension as cause of end-stage renal disease: Lessons from international registriesKidney International, 1998
- Renal hemodynamics in essential hypertension. Racial differences in response to changes in dietary sodium.Hypertension, 1994
- Epidemiologic Analysis of Existing Data to Investigate Hypertensive Renal Disease: An Example From the Maryland End-Stage Renal Disease RegistryAmerican Journal of Kidney Diseases, 1993
- End-Stage Renal Disease in US Minority GroupsAmerican Journal of Kidney Diseases, 1992
- The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980-85.American Journal of Public Health, 1987
- Racial Differences in the Incidence of Treatment for End-Stage Renal DiseaseNew England Journal of Medicine, 1982
- Treatment of End-Stage Renal DiseaseNew England Journal of Medicine, 1980
- Pathophysiology of hypertension in blacks and whites. A review of the basis of racial blood pressure differences.Hypertension, 1979
- Renal Vasculature in Essential Hypertension: Racial DifferencesAnnals of Internal Medicine, 1978